NCT03728140 is a NA clinical trial of Self-spent Culture Medium in in Vitro Fertilization, sponsored by Bin Wu.

Who is sponsoring NCT03728140?

NCT03728140 is sponsored by Bin Wu.

What drugs are being tested in NCT03728140?

Interventions in NCT03728140: Self-spent Culture Medium.

What condition does NCT03728140 study?

NCT03728140 studies in Vitro Fertilization.

Is NCT03728140 still recruiting?

NCT03728140 is currently completed. Last updated 27 January 2020.

Are results published for NCT03728140?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2020-01-27 · How we verify

NCT03728140

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Embryo Transfer With Self-spent Culture Medium

Completed NA Results posted Last updated 27 January 2020

What this trial tests

NA trial testing Self-spent Culture Medium in in Vitro Fertilization in 335 participants. Completed in 31 December 2019.

Timeline

1 January 2018

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	Bin Wu
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	screening
Enrollment	335
Start date	1 January 2018
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across China

Drugs / interventions tested

Self-spent Culture Medium

Conditions studied

in Vitro Fertilization — all drugs for in Vitro Fertilization →

Sponsor

Bin Wu

Who can join

Adults 25 to 35, female only, with in Vitro Fertilization. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants Pregnant After 4 Weeks Primary · 4 weeks

Observe the clinical pregnancy rate under different embryo transfer methods

Group	Value	95% CI
Self-spent Culture Medium	85
New Culture Medium	82

Live Birth Primary · 40 weeks

Observe the live birth rate under different embryo transfer methods

Group	Value	95% CI
Self-spent Culture Medium	78
New Culture Medium	74

Sponsor's own description

Embryo Transfer With Self-spent Culture Medium or new Culture Medium in Vitro Fertilization - Embryo Transfer Process, to analyze which way can improve clinical pregnancy outcomes, is there a significant difference between the two?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for in Vitro Fertilization

Currently open trials in the same condition.

NCT07020546 — Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score · NA · recruiting
NCT06604091 — Cohort Profile：The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart) · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03728140 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bin Wu
Last refreshed: 27 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03728140.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing